Skip to main content

New prosthetic ankle is successfully implanted

| News

New prosthetic ankle is successfully implanted


The world renowned surgeon from Basel, Beat Hintermann, has successfully implanted ankle prosthesis of his own design in five patients in Liestal. Hintermann products are distributed by the U.S. company DT MedTech LLC.

(img: KSBL)

Beat Hintermann is a world renowned foot and ankle surgeon. He is also a professor at the University of Basel and has developed a range of ankle prosthesis known as the Hintermann Series.

Since 2016, these prosthesis have been produced and distributed by the U.S. company DT MedTech LLC.

Now, DT MedTech has announced that Hintermann has successfully implanted his new two-component, semi-constrained total ankle prosthesis in five patients in Liestal.

Four of the procedures were total ankle replacements and the fifth was a takedown of a mal-position arthrodesis.

The new development is indicated for painful arthritic ankle joints due to primary osteoarthritis, post-traumatic osteoarthritis, or arthritis secondary to inflammatory disease.

The prosthesis can also be used as a revision for failed ankle replacements or non-union and mal-union of immobile ankle joints.

“I am extremely pleased with the outcomes of the recent H2 surgeries performed, especially as the patients were able to bear their own weight just 24 hours after the devices were implanted,” commented Hintermann in the statement.

Thanks to the new prosthesis, he can expand patient selection for total ankle replacements.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.